Literature DB >> 7542361

Brief report: correction of X-linked hyper-IgM syndrome by allogeneic bone marrow transplantation.

C Thomas1, G de Saint Basile, F Le Deist, D Theophile, M Benkerrou, E Haddad, S Blanche, A Fischer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7542361     DOI： 10.1056/NEJM199508173330705

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  16 in total

Review 1.  The molecular pathology of primary immunodeficiencies.

Authors:  Megan S Lim; Kojo S J Elenitoba-Johnson
Journal:  J Mol Diagn       Date:  2004-05       Impact factor: 5.568

Review 2.  Stem cell transplantation for immunodeficiency.

Authors:  A Fischer; E Haddad; N Jabado; J L Casanova; S Blanche; F Le Deist; M Cavazzana-Calvo
Journal:  Springer Semin Immunopathol       Date:  1998

Review 3.  The hyper-IgM (HIM) syndrome.

Authors:  N Ramesh; M Seki; L D Notarangelo; R S Geha
Journal:  Springer Semin Immunopathol       Date:  1998

Review 4.  Recent advances in transplantation for primary immune deficiency diseases: a comprehensive review.

Authors:  M Teresa de la Morena; Robert P Nelson
Journal:  Clin Rev Allergy Immunol       Date:  2014-04       Impact factor: 8.667

Review 5.  The hyper IgM syndromes.

Authors:  Nashmia Qamar; Ramsay L Fuleihan
Journal:  Clin Rev Allergy Immunol       Date:  2014-04       Impact factor: 8.667

6.  Bone marrow transplantation for CD40 ligand deficiency: a single centre experience.

Authors:  K Khawaja; A R Gennery; T J Flood; M Abinun; A J Cant
Journal:  Arch Dis Child       Date:  2001-06       Impact factor: 3.791

Review 7.  [Transplantation of hematopoietic stem cells. II: Indications for transplantation of hematopoietic stem cells after myeloablative therapy].

Authors:  H Link; H J Kolb; W Ebell; D K Hossfeld; A Zander; D Niethammer; H Wandt; H Grosse-Wilde; U W Schaefer
Journal:  Med Klin (Munich)       Date:  1997-09-15

8.  Absence of platelet CD40L identifies patients with X-linked hyper IgM syndrome.

Authors:  D P Inwald; M J Peters; D Walshe; A Jones; E G Davies; N J Klein
Journal:  Clin Exp Immunol       Date:  2000-06       Impact factor: 4.330

Review 9.  The hyper IgM syndrome.

Authors:  R L Fuleihan
Journal:  Curr Allergy Asthma Rep       Date:  2001-09       Impact factor: 4.806

10.  Long-term outcomes of 176 patients with X-linked hyper-IgM syndrome treated with or without hematopoietic cell transplantation.

Authors:  M Teresa de la Morena; David Leonard; Troy R Torgerson; Otavio Cabral-Marques; Mary Slatter; Asghar Aghamohammadi; Sharat Chandra; Luis Murguia-Favela; Francisco A Bonilla; Maria Kanariou; Rongras Damrongwatanasuk; Caroline Y Kuo; Christopher C Dvorak; Isabelle Meyts; Karin Chen; Lisa Kobrynski; Neena Kapoor; Darko Richter; Daniela DiGiovanni; Fatima Dhalla; Evangelia Farmaki; Carsten Speckmann; Teresa Español; Anna Shcherbina; Imelda Celine Hanson; Jiri Litzman; John M Routes; Melanie Wong; Ramsay Fuleihan; Suranjith L Seneviratne; Trudy N Small; Ales Janda; Liliana Bezrodnik; Reinhard Seger; Andrea Gomez Raccio; J David M Edgar; Janet Chou; Jordan K Abbott; Joris van Montfrans; Luis Ignacio González-Granado; Nancy Bunin; Necil Kutukculer; Paul Gray; Gisela Seminario; Srdjan Pasic; Victor Aquino; Christian Wysocki; Hassan Abolhassani; Morna Dorsey; Charlotte Cunningham-Rundles; Alan P Knutsen; John Sleasman; Beatriz Tavares Costa Carvalho; Antonio Condino-Neto; Eyal Grunebaum; Helen Chapel; Hans D Ochs; Alexandra Filipovich; Mort Cowan; Andrew Gennery; Andrew Cant; Luigi D Notarangelo; Chaim M Roifman
Journal:  J Allergy Clin Immunol       Date:  2016-09-30       Impact factor: 10.793
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.